推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 21日從市衛(wèi)生計(jì)生委獲悉，以后全市各醫(yī)療機(jī)構(gòu)間將共享存在缺陷的“問題”中藥飲片供貨單位信息，并根據(jù)偽劣中藥飲片種類風(fēng)險(xiǎn)預(yù)警在采購環(huán)節(jié)加以重點(diǎn)鑒別，嚴(yán)防不合格中藥飲片在本市醫(yī)療機(jī)構(gòu)流通。在滿足采購需求的同時(shí)，各醫(yī)療機(jī)構(gòu)將逐年減少中藥飲片供貨單位的數(shù)量，定期淘汰有缺陷的中藥飲片供貨單位。
以后，全市各醫(yī)療機(jī)構(gòu)在采購中藥飲片時(shí)，將定期到生產(chǎn)和經(jīng)營企業(yè)實(shí)地考察、驗(yàn)證，保證中藥飲片生產(chǎn)、經(jīng)營企業(yè)資質(zhì)真實(shí)性，杜絕“掛靠”“皮包公司”等情況發(fā)生。由于目前基層醫(yī)療機(jī)構(gòu)中藥專業(yè)技術(shù)人員匱乏，為保證轄區(qū)內(nèi)醫(yī)療機(jī)構(gòu)中藥飲片質(zhì)量，各區(qū)縣衛(wèi)生行政部門將組織轄區(qū)內(nèi)醫(yī)療機(jī)構(gòu)成立中藥飲片質(zhì)量管理聯(lián)誼會(huì)，負(fù)責(zé)轄區(qū)內(nèi)二級以下醫(yī)療機(jī)構(gòu)中藥飲片質(zhì)量管控工作。選擇2至5家能保證中藥飲片質(zhì)量且具備質(zhì)量檢驗(yàn)?zāi)芰Φ闹兴庯嬈┴泦挝?，供轄區(qū)內(nèi)二級以下醫(yī)療機(jī)構(gòu)選定。
本市將同時(shí)提升醫(yī)療機(jī)構(gòu)中藥飲片入庫驗(yàn)收能力，要求二級以上醫(yī)院應(yīng)具有中級以上專業(yè)技術(shù)職稱和中藥飲片鑒別經(jīng)驗(yàn)的人員，一級醫(yī)院具有初級以上專業(yè)技術(shù)職稱和中藥飲片鑒別經(jīng)驗(yàn)的人員。
